These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17131311)

  • 1. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
    Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
    Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based organized cervical cancer screening pilot program in France.
    Hamers FF; Duport N; Beltzer N
    Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National registry of cervical cytologic diagnoses in The Netherlands.
    Vooijs GP; Casparie-van Velsen IA; Peters FA; Beck HL
    Acta Cytol; 1989; 33(6):825-30. PubMed ID: 2588915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural and temporal compliance to cervical cancer screening guidelines in a CDC-funded program in Alaska.
    Anderson KJ; Speranza PD
    J Low Genit Tract Dis; 2011 Apr; 15(2):98-104. PubMed ID: 21169865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Summary of the practice guideline 'Prevention and early diagnosis of cervical cancer' of the Dutch College of General Practitioners].
    Janssen PG; Boomsma LJ; Buis PA; Collette C; Boukes FS; Goudswaard AN
    Ned Tijdschr Geneeskd; 2009; 153():A517. PubMed ID: 20051149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for prevention of cervical cancer in the Czech Republic].
    Tachezy R; Rob L
    Cas Lek Cesk; 2007; 146(12):939-44. PubMed ID: 18257411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
    Alves C; Alves L; Lunet N
    Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The coverage of cervical screening in Hungary].
    Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
    Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
    Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
    Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the follow-up of women aged 50-74 years after cervical cytological Ascus abnormalities in cancer screening: adherence to clinical practice guidelines in Isere, France; 1991-2000].
    Billette-de-Villemeur A; Poncet F; Garnier A; Marron J; Le Marc'hadour F; Morens A; Rouault-Plantaz V; Ney M; Exbrayat C
    Gynecol Obstet Fertil; 2009 Oct; 37(10):787-95. PubMed ID: 19782628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.